Erratum: Evaluation of molecular forms of PSA and human kallikrein 2 in predicting biochemical failure following radical prostatectomy (International Journal of Cancer (2009) 125 (659-663) DOI:10.1002/ijc.23983)

Registros relacionados

• Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.
  por: Wenske, S, et al.
  Publicado em: (2009)
• Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
  por: Steuber, T, et al.
  Publicado em: (2006)
• Cochrane review of electronic cigarettes for smoking cessation (10.1002/14651858.CD010216.pub9)
  por: Butler, A, et al.
  Publicado em: (2024)
• Is anti-viral defence the evolutionary origin of mRNA turnover? (Comment on DOI 10.1002/bies.201600100).
  por: Rehwinkel, J
  Publicado em: (2016)
• Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
  por: O'Brien, M, et al.
  Publicado em: (2009)